In silico analysis of SARS-CoV-2 spike protein N501Y and N501T mutation effects on human ACE2 binding
Copyright © 2022 Elsevier Inc. All rights reserved..
The SARS-CoV-2 is an RNA-based virus and the most vital step of its survival is the attachment to hACE2 through its spike protein. Although SARS-CoV-2 has the ability to maintain high accurate replication and it can be accepted as a low mutation risked virus, it already showed more than nine thousand mutations in spike protein, of which 44 mutations are located within a 3.2 Å interacting distance from the hACE2 receptor. Mutations on spike protein, N501Y and N501T raised serious concerns for higher transmissibility and resistance towards current vaccines. In the current study, the mutational outcomes of N501Y and N501T on the hACE2-SARS CoV-2 spike protein complexation were analyzed by employing all-atom classic molecular dynamics (MD) simulations. These simulations revealed that both N501Y and N501T mutations increased the binding strength of spike protein to the host hACE2, predicted by binding free energy analysis via MM/GBSA rescoring scheme. This study highlights the importance of energy-based analysis for identifying mutational outcomes and will shed light on handling long-term and effective treatment strategies including repurposing anti-viral drugs, anti-SARS-CoV-2 antibodies, vaccines, and antisense based-therapies.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:116 |
---|---|
Enthalten in: |
Journal of molecular graphics & modelling - 116(2022) vom: 01. Nov., Seite 108260 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Çubuk, Hasan [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 15.08.2022 Date Revised 21.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.jmgm.2022.108260 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM343300001 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM343300001 | ||
003 | DE-627 | ||
005 | 20231226020124.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jmgm.2022.108260 |2 doi | |
028 | 5 | 2 | |a pubmed24n1144.xml |
035 | |a (DE-627)NLM343300001 | ||
035 | |a (NLM)35809511 | ||
035 | |a (PII)S1093-3263(22)00139-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Çubuk, Hasan |e verfasserin |4 aut | |
245 | 1 | 0 | |a In silico analysis of SARS-CoV-2 spike protein N501Y and N501T mutation effects on human ACE2 binding |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.08.2022 | ||
500 | |a Date Revised 21.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 Elsevier Inc. All rights reserved. | ||
520 | |a The SARS-CoV-2 is an RNA-based virus and the most vital step of its survival is the attachment to hACE2 through its spike protein. Although SARS-CoV-2 has the ability to maintain high accurate replication and it can be accepted as a low mutation risked virus, it already showed more than nine thousand mutations in spike protein, of which 44 mutations are located within a 3.2 Å interacting distance from the hACE2 receptor. Mutations on spike protein, N501Y and N501T raised serious concerns for higher transmissibility and resistance towards current vaccines. In the current study, the mutational outcomes of N501Y and N501T on the hACE2-SARS CoV-2 spike protein complexation were analyzed by employing all-atom classic molecular dynamics (MD) simulations. These simulations revealed that both N501Y and N501T mutations increased the binding strength of spike protein to the host hACE2, predicted by binding free energy analysis via MM/GBSA rescoring scheme. This study highlights the importance of energy-based analysis for identifying mutational outcomes and will shed light on handling long-term and effective treatment strategies including repurposing anti-viral drugs, anti-SARS-CoV-2 antibodies, vaccines, and antisense based-therapies | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Effect of mutations on binding energy | |
650 | 4 | |a Molecular Dynamics simulations | |
650 | 4 | |a N501Y and N501T mutations | |
650 | 4 | |a SARS-CoV-2 mutations | |
650 | 4 | |a hACE2-SARS-CoV-2 spike protein binding | |
650 | 7 | |a Receptors, Virus |2 NLM | |
650 | 7 | |a Spike Glycoprotein, Coronavirus |2 NLM | |
650 | 7 | |a spike protein, SARS-CoV-2 |2 NLM | |
650 | 7 | |a Peptidyl-Dipeptidase A |2 NLM | |
650 | 7 | |a EC 3.4.15.1 |2 NLM | |
650 | 7 | |a Angiotensin-Converting Enzyme 2 |2 NLM | |
650 | 7 | |a EC 3.4.17.23 |2 NLM | |
700 | 1 | |a Özbi L, Mehmet |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of molecular graphics & modelling |d 1998 |g 116(2022) vom: 01. Nov., Seite 108260 |w (DE-627)NLM092915620 |x 1873-4243 |7 nnns |
773 | 1 | 8 | |g volume:116 |g year:2022 |g day:01 |g month:11 |g pages:108260 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jmgm.2022.108260 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 116 |j 2022 |b 01 |c 11 |h 108260 |